NEW YORK and LONDON, Oct. 2, 2013 (GLOBE NEWSWIRE) -- Celsus Therapeutics (OTCQB:CLSXY), an emerging growth, development-stage biopharmaceutical company, announced today the addition of biopharmaceutical industry veteran Allan Shaw to the Company’s Board of Directors. Mr. Shaw will serve as Chairman of the Audit Committee.
Help employers find you! Check out all the jobs and post your resume.
